Estimates Revisions BioNTech SE Boerse Muenchen
Stocks
22UA
US09075V1026
Biotechnology & Medical Research
|
Market Closed -
Boerse Muenchen
21:43:26 11/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 83.55 EUR | +0.66% |
|
-6.39% | +2.77% |
| 09-11 | Biontech Insider Sold Shares Worth $1,974,287, According to a Recent SEC Filing | MT |
| 09-10 | European Equities Traded in the US as American Depositary Receipts Drop in Thursday Trading | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Data source:
BioNTech SE(BNTX)
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Data source:
BioNTech SE(BNTX)
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
Data source:
BioNTech SE(BNTX)
EBIT
Dividend / Share (DPS)
Data source:
BioNTech SE(BNTX)
Cash or Net Debt
- Stock Market
- Stocks
- BNTX Stock
- 22UA Stock
- Consensus BioNTech SE
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
